These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15967062)

  • 1. Asymptomatic reboxetine overdose.
    Bandinelli PL; Polselli GM
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):257. PubMed ID: 15967062
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary retention with reboxetine-fluoxetine combination in a young man.
    Benazzi F
    Can J Psychiatry; 2000 Dec; 45(10):936. PubMed ID: 11190365
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study.
    Kasper S
    Psychopharmacology (Berl); 2002 Feb; 159(4):445-6. PubMed ID: 11823898
    [No Abstract]   [Full Text] [Related]  

  • 4. Sleepwalking associated with reboxetine in a young female patient with major depression--a case report.
    Künzel HE; Schuld A; Pollmächer T
    Pharmacopsychiatry; 2004 Nov; 37(6):307-8. PubMed ID: 15551201
    [No Abstract]   [Full Text] [Related]  

  • 5. Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.
    Fava M; McGrath PJ; Sheu WP;
    J Clin Psychopharmacol; 2003 Aug; 23(4):365-9. PubMed ID: 12920412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reboxetine and treatment-refractory elderly patients with depression.
    Chue P
    Can J Psychiatry; 2000 Sep; 45(7):669. PubMed ID: 11056834
    [No Abstract]   [Full Text] [Related]  

  • 7. Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition.
    Sivrioglu EY; Topaloglu VC; Sarandol A; Akkaya C; Eker SS; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):548-50. PubMed ID: 17123681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reboxetine-induced spontaneous ejaculation.
    O'Flynn R; Michael A
    Br J Psychiatry; 2000 Dec; 177():567-8. PubMed ID: 11102344
    [No Abstract]   [Full Text] [Related]  

  • 9. Reboxetine-induced hypomania.
    Vieta E; Colom F; Martínez-Arán A; Reinares M; Benabarre A; Corbella B; Gastó C
    J Clin Psychiatry; 2001 Aug; 62(8):655-6. PubMed ID: 11561941
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine.
    Koelkebeck K; Domschke K; Zwanzger P; Hetzel G; Lang D; Arolt V
    World J Biol Psychiatry; 2009; 10(4 Pt 2):609-11. PubMed ID: 17965988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reboxetine treatment and pseudopheochromocytoma.
    Zornitzki T; Knobler H; Schattner A
    QJM; 2007 Jan; 100(1):61-2. PubMed ID: 17175558
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyponatremia associated with the initiation of reboxetine therapy.
    Abdelrahman N; Kleinman Y; Rund D; Da'as N
    Eur J Clin Pharmacol; 2003 Jun; 59(2):177. PubMed ID: 12734611
    [No Abstract]   [Full Text] [Related]  

  • 13. Reboxetine addition in patients with mirtazapine-resistant depression: a case series.
    López-Muñoz F; Rubio G; Alamo C; García-García P; Pardo A
    Clin Neuropharmacol; 2006; 29(4):192-6. PubMed ID: 16855420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reboxetine and hyponatremia.
    Ranieri P; Franzoni S; Trabucchi M
    N Engl J Med; 2000 Jan; 342(3):215-6. PubMed ID: 10651558
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of reboxetine on human sleep architecture in depression: preliminary results.
    Farina B; Della Marca G; Mennuni G; Mazza S; De Risio S; Di Giannantonio M
    J Affect Disord; 2002 Sep; 71(1-3):273-5. PubMed ID: 12167528
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S; Bodlund O; Agren H
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine associated with thrombocytopenia and treatment with reboxetine: 3 cases.
    Yucel A; Yucel N; Ozcan H; Gulec M; Aydin A
    J Clin Psychopharmacol; 2015 Jun; 35(3):354-5. PubMed ID: 25822478
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.
    Clayton AH; Zajecka J; Ferguson JM; Filipiak-Reisner JK; Brown MT; Schwartz GE
    Int Clin Psychopharmacol; 2003 May; 18(3):151-6. PubMed ID: 12702894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin for reboxetine-induced urinary hesitancy.
    Szabadi E
    Br J Psychiatry; 1998 Nov; 173():441-2. PubMed ID: 9926068
    [No Abstract]   [Full Text] [Related]  

  • 20. Reboxetine in depression. All the relevant data?
    Turner EH
    BMJ; 2010 Nov; 341():c6487. PubMed ID: 21081614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.